Conditionally replicative adenovirus driven by the human telomerase promoter provides broad-spectrum antitumor activity without liver toxicity.
Saved in:
| Title: | Conditionally replicative adenovirus driven by the human telomerase promoter provides broad-spectrum antitumor activity without liver toxicity. |
|---|---|
| Authors: | Irving J; Geron Corporation, Menlo Park, California 94025, USA., Wang Z, Powell S, O'Sullivan C, Mok M, Murphy B, Cardoza L, Lebkowski JS, Majumdar AS |
| Source: | Cancer gene therapy [Cancer Gene Ther] 2004 Mar; Vol. 11 (3), pp. 174-85. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9432230 Publication Model: Print Cited Medium: Print ISSN: 0929-1903 (Print) Linking ISSN: 09291903 NLM ISO Abbreviation: Cancer Gene Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
